Product NDC: | 49158-501 |
Proprietary Name: | Enalapril Maleate |
Non Proprietary Name: | Enalapril Maleate |
Active Ingredient(s): | 5 mg/1 & nbsp; Enalapril Maleate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 49158-501 |
Labeler Name: | Taro Pharmaceuticals U.S.A., Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075657 |
Marketing Category: | ANDA |
Start Marketing Date: | 20010123 |
Package NDC: | 49158-501-10 |
Package Description: | 100 TABLET in 1 BOTTLE (49158-501-10) |
NDC Code | 49158-501-10 |
Proprietary Name | Enalapril Maleate |
Package Description | 100 TABLET in 1 BOTTLE (49158-501-10) |
Product NDC | 49158-501 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Enalapril Maleate |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20010123 |
Marketing Category Name | ANDA |
Labeler Name | Taro Pharmaceuticals U.S.A., Inc. |
Substance Name | ENALAPRIL MALEATE |
Strength Number | 5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Angiontensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Decreased Blood Pressure [PE] |